Tabl, A. M., Ebeid, M. E., Ali, Y. B. M., Elawdan, K. A., Alalem, M., Al-Eidan, A. A., . . . Khalil, H. (2026). Nanomodified Nexavar Enhances Efficacy in Caco-2 Cells via Targeting Aspartate β-Hydroxylase-Driven Mitochondrial Cell Death. Immuno, 6(1), 5. https://doi.org/10.3390/immuno6010005
Chicago Style (17th ed.) CitationTabl, Ahmed M., et al. "Nanomodified Nexavar Enhances Efficacy in Caco-2 Cells via Targeting Aspartate β-Hydroxylase-Driven Mitochondrial Cell Death." Immuno 6, no. 1 (2026): 5. https://doi.org/10.3390/immuno6010005.
MLA (9th ed.) CitationTabl, Ahmed M., et al. "Nanomodified Nexavar Enhances Efficacy in Caco-2 Cells via Targeting Aspartate β-Hydroxylase-Driven Mitochondrial Cell Death." Immuno, vol. 6, no. 1, 2026, p. 5, https://doi.org/10.3390/immuno6010005.